Clinical trial

Clinico-biological Data Collection Study of Metastatic Breast Cancer

NCT03958136

StatusACTIVE_NOT_RECRUITING

Study typeINTERVENTIONAL

Start date2018-12-24

PhaseNA

Study timeline

Study start (actual)2018-12-24Date precision: day

Registry last updated2025-08-17

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Breast Cancerunresolved

Interventions

Metastasis biopsyPROCEDURE

Biomarkers blood, urine and microbiota samplesBIOLOGICAL

Patient Reported Outcome (PRO)BEHAVIORAL

Sponsors & collaborators

Institut Cancerologie de l'Ouestlead sponsor

European Regional Development Fundcollaborator

AstraZenecacollaborator

Novartiscollaborator

Eli Lilly and Companycollaborator

Mapped research locations

AngersFrance1 Saint-HerblainFrance1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT03958136 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.